Articles tagged with Mycobacteria
A promising TB vaccine candidate, Mtb Δppe25-pe19, induces a strong and diverse immune response to all mycobacterial PE/PPE proteins, offering insights into its protective efficacy. Unlike BCG, the new strain has an intact ESX-1 transport system, allowing it to induce phagosomal rupture and provoke innate immune responses.
A new study found that individual mycobacteria respond differently to antibiotics based on growth and timing, shedding light on the complexity of antibiotic tolerance. Bacteria in different stages of their cell cycle and size are susceptible to varying degrees.
Researchers have developed a new method to detect mycobacterial pathogens directly from patient samples using genetic analysis, reducing detection time to 1-2 days. The new method was found to be equally accurate as traditional culture-based techniques and can also detect resistance to standard medicines.
Researchers have developed an olive oil-based emulsion that improves the efficacy of Mycobacterium brumae in treating bladder cancer. The emulsion reduces clumping and preserves mycobacteria viability, providing a promising delivery vehicle for this treatment.
Researchers at the University of Nottingham have developed a new blood test that detects Mycobacteria in blood with high sensitivity. The test delivers results within 48 hours and has been shown to detect the bacterium M. bovis in cattle diagnosed with bovine tuberculosis (bTB) with high accuracy.
Researchers identified a novel tuberculosis pathogen, Mycobacterium mungi, transmitted through environmental urine and anal gland secretions in banded mongooses. This discovery radically changes the understanding of TB transmission, with implications for wildlife and livestock health.
A team of researchers from NTNU clarified a crucial step in the mechanism that allows mycobacteria to evade the immune system by hiding in macrophages. This finding adds to our understanding of the general mechanisms of how the immune system works, particularly in relation to inflammation and its regulation.
Researchers identified bi-allelic mutations in RORC, essential for IL-17-producing T cells against Candida and IFN-γ-producing T cells against Mycobacterium. This study reveals a new understanding of genetic susceptibility to these infections.
Researchers at Rockefeller University have identified a genetic error that makes children susceptible to two unrelated diseases: aggravating fungal infections and invasive, potentially fatal bacterial disease. The mutation affects the RORC gene, which controls the production of cytokines crucial for fighting off mycobacteria.
Researchers at the University of Otago have discovered a key mechanism that enables mycobacteria to survive in extreme conditions, using hydrogen as a high-energy fuel. By understanding this metabolic process, scientists hope to develop new antibiotics to tackle latent tuberculosis infections.
Acetic acid in vinegar effectively kills drug-resistant tuberculosis bacteria and other stubborn mycobacteria. A 6% solution of acetic acid for 30 minutes reduces TB mycobacteria to undetectable levels, posing a low-risk alternative to toxic disinfectants.
Researchers discovered that invariant natural killer T cells produce and release GM-CSF to control Mycobacterium tuberculosis growth. This finding provides insight into the immune system's ability to combat TB.
A skin infection linked to aquariums is frequently under-diagnosed due to its delayed appearance. Researchers say patients often fail to remember the source of exposure, leading to delayed treatment and ineffective use of antifungal agents.
Researchers have created a comprehensive map of the tuberculosis protein, allowing scientists to pinpoint specific proteins and discover new ones. This resource may aid in the development of new therapies and early detection methods, targeting the main target for medication: pathogen proteins.
Researchers have discovered a unique defence mechanism of the tuberculosis pathogen Mycobacterium tuberculosis, which protects sulphur-containing proteins from oxidation. The protein mycoredoxin-1 plays a crucial role in this repair mechanism, and disabling it may offer new ways to combat the disease.
Research confirms long-term azithromycin treatment increases infection with nontuberculous mycobacteria, a serious complication in cystic fibrosis. Azithromycin blocks autophagy, impairing immune cells' ability to kill bacteria.
A recent study confirms that long-term azithromycin treatment is associated with increased infection with nontuberculous mycobacteria, a serious complication in cystic fibrosis patients. The team identified autophagy impairment as the underlying mechanism, highlighting a clinical danger of pharmacological blockade.
Researchers at VIB and Ghent University have developed a new tuberculosis vaccine that affords better protection against the disease by triggering an immune reaction in the body. The new vaccine works differently from existing vaccines and acquires its extra protective value by emitting signals that provoke inflammation.
Scientists at EMBL identified a multi-tasking protein PriA from Mycobacterium tuberculosis that catalyzes reactions on two different molecules. This finding presents new opportunities for developing organism-specific drugs, targeting the pathogen but leaving other beneficial microorganisms untouched.
Two iron compounds have been synthesized to inhibit the growth of Mycobacterium tuberculosis in vitro. The compounds showed low toxicity in mammalian cells, making them promising candidates for treating tuberculosis and serving as hospital disinfectants.
A computer model found a network of genes that can trigger TB's dormant state, switching it from fast-growing to slow-growing. The study reveals potential for a persistence switch that could explain why TB is so widespread and deadly.
Researchers discovered that mycobacteria block phagosome maturation with acyltrehalose-containing glycolipids, surviving and thriving inside host macrophages. This study sheds light on the mechanism of intracellular parasitism and identifies potential new drug targets for TB treatment.
The study aims to understand how enzymes activate molecular oxygen and attach it to substrate molecules to synthesize siderophores, essential for the microbes' metabolic needs. The researchers will use protein crystallography training to train global scientists and students.
Researchers at Iowa State University have identified an enzyme that helps make tuberculosis resistant to a human's natural defense system. A new method to neutralize this enzyme may lead to a cure for the disease, which kills 1.5 to 2 million people worldwide annually.
A large study found pulmonary NTM disease increasing significantly in men and women in Florida and New York, with no changes in California. The disease is more common among women, particularly in the fifth or sixth decade of life.
A CU-Boulder study found that 30% of showerheads harbor significant levels of Mycobacterium avium, a pathogen linked to pulmonary disease. The researchers discovered biofilms on the inside of showerheads containing high loads of M. avium and related pathogens.
A study has found that a mutation in the NOD2 gene may predispose individuals to Crohn's disease by impairing the immune system's ability to recognize and fight off mycobacteria. The research, published in the Journal of Experimental Medicine, highlights the potential for new therapeutic approaches to combat the disease.
A Uppsala University research group has made a groundbreaking discovery that mycobacteria, the bacteria causing tuberculosis, can form spores. This finding challenges long-held beliefs and opens up new possibilities for understanding how these bacteria cause latent infections.
A 4000-year-old skeleton from India reveals the earliest archaeological evidence of human infection with Mycobacterium leprae, shedding light on prehistoric transmission routes and challenges popular misconceptions about the disease. The findings support a hypothesis that leprosy spread between Africa and Asia during urbanization periods.
Researchers found that Mycobacterium tuberculosis converts NO2 to NO using coenzyme F420, protecting itself from oxidative damage. This defense mechanism allows the bacteria to survive in the human immune system and stay dormant until the system is weakened.
Researchers have discovered a new species of leprosy-causing bacteria, Mycobacterium lepromatosis, which attacks skin vasculature and leads to extensive skin death. The finding could account for geographical and individual variation in the disease's severity.
Researchers have elucidated the mechanism of iron uptake system in M. tuberculosis, a promising target for intervention. The study reveals an exporter-importer system that exports siderophores and imports iron-bound forms, providing a crucial foothold to tame this deadly pathogen.
Researchers have developed an assay to identify antibodies specific to Mycobacterium avium complex (MAC), distinguishing MAC-related pulmonary disease from tuberculosis in under eight hours. The test showed high sensitivity and specificity, reducing the risk of misdiagnosis and inappropriate treatment.
A team of researchers has isolated and characterized Mycobacterium ulcerans from the environment, supporting the idea that it is transmitted to humans through aquatic niches. The discovery lends support to efforts to control Buruli ulcer, a disease with massive social impact in impoverished tropical regions.
Researchers found that Mycobacterium paratuberculosis, a bacterium causing cattle illness, triggers Crohn's disease in humans by releasing a molecule preventing white blood cells from killing E.coli bacteria. The team suggests dairy products, including cow milk, may be the entry point for this bacterium.
Researchers found that Mycobacterium indicus pranii (MIP) is the earliest ancestor of generalist mycobacterial pathogens, including Crohn's disease pathogen M. avium paratuberculosis (MAP). The study suggests that MIP and MAP descended from a common ancestor and infected marine organisms before arriving on soil through bird-droppings.
A K-State professor is researching a new strategy to treat tuberculosis by targeting the channel proteins called porins in Mycobacterium tuberculosis. His goal is to develop supramolecular model systems that can block these channels, permanently deactivating TB and allowing the human immune system to deal with it.
The study reveals that overexpression of Pkn protein leads to a cell shape defect. The findings suggest that this mechanism is widely conserved among gram-positive bacteria, with related signaling molecules present in multiple species.
Researchers Andrea Cooper and Julie Inamine are investigating why Mycobacterium avium causes disease in AIDS patients despite humans not being natural hosts. The studies aim to identify genes responsible for the bacteria's virulence and develop drugs to prevent disease.